Literature DB >> 22001091

Anisotropy studies of tRNA-T box antiterminator RNA complex in the presence of 1,4-disubstituted 1,2,3-triazoles.

S Zhou1, G Acquaah-Harrison, S C Bergmeier, J V Hines.   

Abstract

The binding of tRNA to the T box antiterminator RNA element is a critical component of the T box riboswitch mechanism that regulates essential genes in many Gram-positive bacteria. A series of 1,4-disubstituted 1,2,3-triazoles was screened for disruption of the tRNA-T box antiterminator RNA interaction using a fluorescence anisotropy-based assay. Several compounds reduced the anisotropy greater than 50% likely indicating significant competition for binding antiterminator RNA. General structure-activity trends indicated that the substituents at both N-1 and C-4 likely are involved in ligand binding. In addition, the anisotropy of the complex was significantly decreased not only by ligands with the possibility for electrostatic interactions with the RNA, but also by ligands with the potential for π-π stacking or other hydrophobic interactions indicating that these non-electrostatic interactions could possibly be utilized in the future development of compounds that target and disrupt the function of this medicinally important riboswitch. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001091      PMCID: PMC3466059          DOI: 10.1016/j.bmcl.2011.09.095

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Biochemical features and functional implications of the RNA-based T-box regulatory mechanism.

Authors:  Ana Gutiérrez-Preciado; Tina M Henkin; Frank J Grundy; Charles Yanofsky; Enrique Merino
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

3.  Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.

Authors:  Crina M Orac; Shu Zhou; John A Means; David Boehm; Stephen C Bergmeier; Jennifer V Hines
Journal:  J Med Chem       Date:  2011-08-31       Impact factor: 7.446

4.  In vitro structure-function studies of the Bacillus subtilis tyrS mRNA antiterminator: evidence for factor-independent tRNA acceptor stem binding specificity.

Authors:  Melinda S Gerdeman; Tina M Henkin; Jennifer V Hines
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

5.  High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.

Authors:  G L Lokesh; Aparna Rachamallu; G D Kishore Kumar; Amarnath Natarajan
Journal:  Anal Biochem       Date:  2006-02-03       Impact factor: 3.365

6.  Structure-activity studies of oxazolidinone analogs as RNA-binding agents.

Authors:  John Means; Steven Katz; Abhijit Nayek; Rajaneesh Anupam; Jennifer V Hines; Stephen C Bergmeier
Journal:  Bioorg Med Chem Lett       Date:  2006-04-05       Impact factor: 2.823

7.  Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.

Authors:  Aviva Lapidot; Veerappan Vijayabaskar; Alexander Litovchick; Jingua Yu; Thomas L James
Journal:  FEBS Lett       Date:  2004-11-19       Impact factor: 4.124

8.  Fluorescence probing of T box antiterminator RNA: insights into riboswitch discernment of the tRNA discriminator base.

Authors:  John A Means; Crystal M Simson; Shu Zhou; Aaron A Rachford; Jeffrey J Rack; Jennifer V Hines
Journal:  Biochem Biophys Res Commun       Date:  2009-09-13       Impact factor: 3.575

9.  4,5-Disubstituted oxazolidinones: High affinity molecular effectors of RNA function.

Authors:  Rajaneesh Anupam; Abhijit Nayek; Nicholas J Green; Frank J Grundy; Tina M Henkin; John A Means; Stephen C Bergmeier; Jennifer V Hines
Journal:  Bioorg Med Chem Lett       Date:  2008-05-06       Impact factor: 2.823

10.  Identification of neomycin B-binding site in T box antiterminator model RNA.

Authors:  Rajaneesh Anupam; Leyna Denapoli; Abigael Muchenditsi; Jennifer V Hines
Journal:  Bioorg Med Chem       Date:  2008-03-07       Impact factor: 3.641

View more
  5 in total

1.  Ligand-induced changes in T box antiterminator RNA stability.

Authors:  Shu Zhou; George Acquaah-Harrison; Karen D Jack; Stephen C Bergmeier; Jennifer V Hines
Journal:  Chem Biol Drug Des       Date:  2011-12-22       Impact factor: 2.817

2.  Factors that influence T box riboswitch efficacy and tRNA affinity.

Authors:  C Zeng; S Zhou; S C Bergmeier; J V Hines
Journal:  Bioorg Med Chem       Date:  2015-07-16       Impact factor: 3.641

3.  Identification of Spermidine Binding Site in T-box Riboswitch Antiterminator RNA.

Authors:  Jia Liu; Chunxi Zeng; Vivian Hogan; Shu Zhou; Md Masud Monwar; Jennifer V Hines
Journal:  Chem Biol Drug Des       Date:  2015-10-05       Impact factor: 2.817

4.  Interfacing medicinal chemistry with structural bioinformatics: implications for T box riboswitch RNA drug discovery.

Authors:  Franziska Jentzsch; Jennifer V Hines
Journal:  BMC Bioinformatics       Date:  2012-03-13       Impact factor: 3.169

5.  Direct modulation of T-box riboswitch-controlled transcription by protein synthesis inhibitors.

Authors:  Vassiliki Stamatopoulou; Maria Apostolidi; Shuang Li; Katerina Lamprinou; Athanasios Papakyriakou; Jinwei Zhang; Constantinos Stathopoulos
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.